'Contributed 12 15 percent' diaporamas de présentation

trend-today

The US FDA inspection of Sun Pharma's crucial Halol site in Gujarat that was widely expected to end on Friday, could possible extend by a day or two, said sources. The facility is under US FDA warning letter since December 2015.The drug maker declined to comment. Dilip Shanghvi, who is attending the India Pharmaceutical Forum, said the company as a policy will not talk on ongoing regulatory inspections. The current US FDA inspection began on February 12.

69 views • 6 slides